B-Raf inhibitor

This page covers all B-Raf inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting B-Raf.

Targets

B-Raf

Phase 2 pipeline (1)

• Anti-B-RAF · Istituto Oncologico Veneto IRCCS · Oncology
  Anti-B-RAF drugs target and inhibit the B-Raf protein, which is often mutated in cancer cells.

Patent intelligence

• b raf inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates